Wegovy 2.4 MG/0.75 ML pen 0.75ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9Z02
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $35,622
Award facts
- Contract value 100% obligated
- $35,622.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $35,622.04 delivery order to AmerisourceBergen Drug Corp (Ultimate Unified Entity Identifier: KABZK8W6PQT3) on January 20, 2026, for the supply of Wegovy 2.4 mg/0.75 mL pens with a completion date of January 21, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be fulfilled at the contractor's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen Drug Corp's parent company, Cencora, Inc. (doing business as AmerisourceBergen), which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031. This primary IDC serves as the vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices to support military healthcare programs globally.
AmerisourceBergen is a major pharmaceutical distributor critical to federal medical procurement, particularly for military and veteran healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to supply diverse pharmaceutical products across multiple therapeutic domains, including diabetes medications, neurological treatments, pain management pharmaceuticals, and specialized medical commodities. The Wegovy delivery order reflects the company's continued role in supplying prescription medications to support Department of Defense healthcare operations and military treatment facilities worldwide.
Quick answers
Who was awarded contract SPE2DR26F9Z02?
SPE2DR26F9Z02 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26F9Z02 worth?
The government has obligated $35,622 on SPE2DR26F9Z02.
Is contract SPE2DR26F9Z02 an order under another contract?
Yes. SPE2DR26F9Z02 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9Z02 competed?
The extent of competition for SPE2DR26F9Z02 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award